Pancreatic Cancer: Pancreatica - 2008: July August September

Pancreatic Cancer News and Archives

For access to the Select Abstracts^sm section, please click here

For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer

2008 Third Quarter

Surgical Approach and Perioperative Complications Determine Short-Term Outcomes in Patients with Insulinoma: Results of a Bi-Institutional Study
September 30, 2008
...more

A Randomized Phase II Trial of Adjuvant Chemotherapy with Uracil/Tegafur and Gemcitabine Versus Gemcitabine Alone in Patients with Resected Pancreatic Cancer
September 29, 2008
...more

Liver Metastases of Neuroendocrine Carcinomas: Interventional Treatment via Transarterial Embolization, Chemoembolization and Thermal Ablation
September 29, 2008
...more

Activated Epidermal Growth Factor Receptor as a Novel Target in Pancreatic Cancer Therapy
September 27, 2008
...more

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
September 26, 2008
...more

A Phase I Radiation Dose-escalation Study to Determine the Maximal Dose of Radiotherapy in Combination with Weekly Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma
September 22, 2008
...more

Anti-tumor Activity of Erlotinib in the BxPC-3 Pancreatic Cancer Cell Line
September 21, 2008
...more

Chemoradiotherapy with Twice-weekly Administration of Low-dose Gemcitabine for Locally Advanced Pancreatic Cancer
September 14, 2008
...more

Liver Perfusion Chemotherapy With 5-Fluorouracil Followed by Systemic Gemcitabine Administration for Resected Pancreatic Cancer: Preliminary Results of a Prospective Phase 2 Study
September 12, 2008
...more

Utilization and Determinants of Adjuvant Therapy Among Older Patients Who Receive Curative Surgery for Pancreatic Cancer
September 12, 2008
...more

Do not Deny Pancreatic Resection to Elderly Patients
September 11, 2008
...more

Synergistic Effects of Acyclic Retinoid and Gemcitabine on Growth Inhibition in Pancreatic Cancer Cells
September 11, 2008
...more

Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-grade Neuroendocrine Tumors: Results of a Phase II Study
September 10, 2008
...more

Phase II Study of 5-Fluorouracil and Paclitaxel in Patients with Gemcitabine-refractory Pancreatic Cancer
September 3, 2008
...more

Clinical Applications of 68Ga-DOTANOC in Neuroendocrine Tumours
September 1, 2008
...more

Matuzumab Short-term Therapy in Experimental Pancreatic Cancer: Prolonged Antitumor Activity in Combination with Gemcitabine
September 1, 2008
...more

Prospective Study on Warfarin and Regional Chemotherapy in Patients with Pancreatic Carcinoma
September 1, 2008
...more

Pilot Study of Combination Chemotherapy using Irinotecan Plus S-1 for Metastatic Pancreatic Cancer
August 28, 2008
...more

Novel Anticancer Agents, Kayeassamins A and B from the Flower of Kayea Assamica of Myanmar
August 15, 2008
...more

Risk Factors Associated with Neuroendocrine Tumors: A U.S.-Based Case-Control Study
August 15, 2008
...more

Synergistic Effects of Multiple Natural Products in Pancreatic Cancer Cells
August 15, 2008
...more

The Combination of Epidermal Growth Factor Receptor Inhibitors with Gemcitabine and Radiation in Pancreatic Cancer
August 15, 2008
...more

Impact of Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Adenocarcinoma of the Body or Tail of the Pancreas
August 13, 2008
...more

Efficacy of Gemcitabine for Locally Advanced Pancreatic Cancer: Comparison with 5-Fluorouracil-based Chemoradiotherapy
August 8, 2008
...more

Adjuvant Interferon-Based Chemoradiation Followed by Gemcitabine Forresected Pancreatic Adenocarcinoma: A Single-Institution Phase II Study
August 1, 2008
...more

Clinical Benefit and Quality of Life in Patients with Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial--SAKK 44/00-CECOG/PAN.1.3.001
August 1, 2008
...more

Incidence, Prevalence, and Management of Intraductal Papillary Mucinous Neoplasm in Olmsted County, Minnesota, 1984-2005: A Population Study
August 1, 2008
...more

Optimizing MIBG Therapy of Neuroendocrine Tumors: Preclinical Evidence of Dose Maximization and Synergy
August 1, 2008
...more

Outcomes Following Pancreatic Resection: Variability among High-volume Providers
August 1, 2008
...more

Prevention and Delay in Progression of Human Pancreatic Cancer by Stable Overexpression of the Opioid Growth Factor Receptor
August 1, 2008
...more

Weekly Docetaxel as Salvage Therapy in Patients with Gemcitabine-refractory Metastatic Pancreatic Cancer
August 1, 2008
...more

Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Series of 30 Patients Collected From 3 Institutions
July 24, 2008
...more

Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation after Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital
July 20, 2008
...more

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
July 20, 2008
...more

Preoperative Gemcitabine-Based Chemoradiation for Patients with Resectable Adenocarcinoma of the Pancreatic Head
July 20, 2008
...more

MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
July 19, 2008
...more

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
July 15, 2008
...more

Activity of Sunitinib in Patients with Advanced Neuroendocrine Tumors
July 10, 2008
...more

Radioembolization with Selective Internal radiation Microspheres for Neuroendocrine Liver Metastases
July 10, 2008
...more

Gemcitabine Based Combination Chemotherapy in Advanced Pancreatic Cancer-Indirect Comparison
July 8, 2008
...more

Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer: Results of Secondary End Points Analyses
July 8, 2008
...more

Prognostic Factors of Long-Term Outcome in Gastroenteropancreatic Neuroendocrine Tumours
July 4, 2008
...more

Chemoprevention by Perillyl Alcohol Coupled with Viral Gene Therapy Reduces Pancreatic Cancer Pathogenesis
July 1, 2008
...more

Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients
July 1, 2008
...more

Comparison of Hyper-fractionated Accelerated and Standard Fractionated Radiotherapy with Concomitant Low-dose Gemcitabine for Unresectable Pancreatic Cancer
July 1, 2008
...more

Endoscopic Ultrasound-guided Ethanol Injection in the Pancreas in a Porcine Model: A Preliminary Study
July 1, 2008
...more

Experience with 208 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas
July 1, 2008
...more

Neuroendocrine Tumors: A registry of 1,000 Patients
July 1, 2008
...more

Phase 2 Trial of Oral S-1 Combined with Low-dose Cisplatin for Unresectable Advanced Pancreatic Cancer
July 1, 2008
...more

Usefulness of S-1/Gemcitabine Combination Therapy for Advanced Pancreatic Cancer
July 1, 2008
...more

For educational purposes only; not to be relied upon
Please read Pancreatica Disclaimer

Home | In The News | Links | Newswire | Donations
FAQ | Clinical Trials Database | Research Resources | About Us

webmaster

©2000-2010 Pancreatica.org - All Rights Reserved
www.pancreatica.org

	Pancreatic Cancer News and Archives *For access to the Select Abstracts^sm section, please click here* For educational purposes only; not to be relied upon. Please read Pancreatica Disclaimer 2008 Third Quarter Surgical Approach and Perioperative Complications Determine Short-Term Outcomes in Patients with Insulinoma: Results of a Bi-Institutional Study September 30, 2008 ...more A Randomized Phase II Trial of Adjuvant Chemotherapy with Uracil/Tegafur and Gemcitabine Versus Gemcitabine Alone in Patients with Resected Pancreatic Cancer September 29, 2008 ...more Liver Metastases of Neuroendocrine Carcinomas: Interventional Treatment via Transarterial Embolization, Chemoembolization and Thermal Ablation September 29, 2008 ...more Activated Epidermal Growth Factor Receptor as a Novel Target in Pancreatic Cancer Therapy September 27, 2008 ...more Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses September 26, 2008 ...more A Phase I Radiation Dose-escalation Study to Determine the Maximal Dose of Radiotherapy in Combination with Weekly Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma September 22, 2008 ...more Anti-tumor Activity of Erlotinib in the BxPC-3 Pancreatic Cancer Cell Line September 21, 2008 ...more Chemoradiotherapy with Twice-weekly Administration of Low-dose Gemcitabine for Locally Advanced Pancreatic Cancer September 14, 2008 ...more Liver Perfusion Chemotherapy With 5-Fluorouracil Followed by Systemic Gemcitabine Administration for Resected Pancreatic Cancer: Preliminary Results of a Prospective Phase 2 Study September 12, 2008 ...more Utilization and Determinants of Adjuvant Therapy Among Older Patients Who Receive Curative Surgery for Pancreatic Cancer September 12, 2008 ...more Do not Deny Pancreatic Resection to Elderly Patients September 11, 2008 ...more Synergistic Effects of Acyclic Retinoid and Gemcitabine on Growth Inhibition in Pancreatic Cancer Cells September 11, 2008 ...more Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-grade Neuroendocrine Tumors: Results of a Phase II Study September 10, 2008 ...more Phase II Study of 5-Fluorouracil and Paclitaxel in Patients with Gemcitabine-refractory Pancreatic Cancer September 3, 2008 ...more Clinical Applications of 68Ga-DOTANOC in Neuroendocrine Tumours September 1, 2008 ...more Matuzumab Short-term Therapy in Experimental Pancreatic Cancer: Prolonged Antitumor Activity in Combination with Gemcitabine September 1, 2008 ...more Prospective Study on Warfarin and Regional Chemotherapy in Patients with Pancreatic Carcinoma September 1, 2008 ...more Pilot Study of Combination Chemotherapy using Irinotecan Plus S-1 for Metastatic Pancreatic Cancer August 28, 2008 ...more Novel Anticancer Agents, Kayeassamins A and B from the Flower of Kayea Assamica of Myanmar August 15, 2008 ...more Risk Factors Associated with Neuroendocrine Tumors: A U.S.-Based Case-Control Study August 15, 2008 ...more Synergistic Effects of Multiple Natural Products in Pancreatic Cancer Cells August 15, 2008 ...more The Combination of Epidermal Growth Factor Receptor Inhibitors with Gemcitabine and Radiation in Pancreatic Cancer August 15, 2008 ...more Impact of Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Adenocarcinoma of the Body or Tail of the Pancreas August 13, 2008 ...more Efficacy of Gemcitabine for Locally Advanced Pancreatic Cancer: Comparison with 5-Fluorouracil-based Chemoradiotherapy August 8, 2008 ...more Adjuvant Interferon-Based Chemoradiation Followed by Gemcitabine Forresected Pancreatic Adenocarcinoma: A Single-Institution Phase II Study August 1, 2008 ...more Clinical Benefit and Quality of Life in Patients with Advanced Pancreatic Cancer Receiving Gemcitabine Plus Capecitabine Versus Gemcitabine Alone: A Randomized Multicenter Phase III Clinical Trial--SAKK 44/00-CECOG/PAN.1.3.001 August 1, 2008 ...more Incidence, Prevalence, and Management of Intraductal Papillary Mucinous Neoplasm in Olmsted County, Minnesota, 1984-2005: A Population Study August 1, 2008 ...more Optimizing MIBG Therapy of Neuroendocrine Tumors: Preclinical Evidence of Dose Maximization and Synergy August 1, 2008 ...more Outcomes Following Pancreatic Resection: Variability among High-volume Providers August 1, 2008 ...more Prevention and Delay in Progression of Human Pancreatic Cancer by Stable Overexpression of the Opioid Growth Factor Receptor August 1, 2008 ...more Weekly Docetaxel as Salvage Therapy in Patients with Gemcitabine-refractory Metastatic Pancreatic Cancer August 1, 2008 ...more Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Series of 30 Patients Collected From 3 Institutions July 24, 2008 ...more Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation after Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital July 20, 2008 ...more Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head July 20, 2008 ...more Preoperative Gemcitabine-Based Chemoradiation for Patients with Resectable Adenocarcinoma of the Pancreatic Head July 20, 2008 ...more MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival July 19, 2008 ...more Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer July 15, 2008 ...more Activity of Sunitinib in Patients with Advanced Neuroendocrine Tumors July 10, 2008 ...more Radioembolization with Selective Internal radiation Microspheres for Neuroendocrine Liver Metastases July 10, 2008 ...more Gemcitabine Based Combination Chemotherapy in Advanced Pancreatic Cancer-Indirect Comparison July 8, 2008 ...more Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer: Results of Secondary End Points Analyses July 8, 2008 ...more Prognostic Factors of Long-Term Outcome in Gastroenteropancreatic Neuroendocrine Tumours July 4, 2008 ...more Chemoprevention by Perillyl Alcohol Coupled with Viral Gene Therapy Reduces Pancreatic Cancer Pathogenesis July 1, 2008 ...more Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients July 1, 2008 ...more Comparison of Hyper-fractionated Accelerated and Standard Fractionated Radiotherapy with Concomitant Low-dose Gemcitabine for Unresectable Pancreatic Cancer July 1, 2008 ...more Endoscopic Ultrasound-guided Ethanol Injection in the Pancreas in a Porcine Model: A Preliminary Study July 1, 2008 ...more Experience with 208 Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas July 1, 2008 ...more Neuroendocrine Tumors: A registry of 1,000 Patients July 1, 2008 ...more Phase 2 Trial of Oral S-1 Combined with Low-dose Cisplatin for Unresectable Advanced Pancreatic Cancer July 1, 2008 ...more Usefulness of S-1/Gemcitabine Combination Therapy for Advanced Pancreatic Cancer July 1, 2008 ...more

	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer


	Home \| In The News \| Links \| Newswire \| Donations FAQ \| Clinical Trials Database \| Research Resources \| About Us

	webmaster

	©2000-2010 Pancreatica.org - All Rights Reserved www.pancreatica.org